Clinical Trial Update: Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase II trial of VDJ001 in patients with moderate-to-severe active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• VDJ001

Snippet

Sponsor: Beijing VDJBio Co., LTD. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED